UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

Annals of oncology, 2016-05, Vol.27 (5), p.920-926

2016

Link zum Volltext

Verfügbarkeit prüfen

Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation

Annals of surgical oncology, 2013-02, Vol.20 (2), p.440-447

2013

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma

Annals of oncology, 2016-10, Vol.27 (10), p.1902-1908

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2017-10, Vol.28 (10), p.2533-2538

2017

Link zum Volltext

Verfügbarkeit prüfen

Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach

Journal of clinical pathology, 2008-12, Vol.61 (12), p.1303-1313

2008

Link zum Volltext

Verfügbarkeit prüfen

Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-07, Vol.28 (7), p.467-474

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2018-07, Vol.29 (7), p.1606-1606

2018

Link zum Volltext

Verfügbarkeit prüfen

Can Metabolic Tumor Volume Further Risk Stratify Patients Eligible for Treatment Deintensification in the Newly Proposed HPV-Associated Oropharyngeal Cancer Staging System?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S173-S173

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Outcomes Following Recurrence or Metastasis in HPV+ and HPV- Oropharyngeal Carcinoma Treated With Definitive Chemoradiation Using IMRT

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E355-E355

2016

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Regional Nodal Failure Following Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E338-E338

2016

Link zum Volltext

Verfügbarkeit prüfen

Natural History Following Recurrence After Definitive Locoregional Treatment in 1000+ Cases of Locally Advanced Head and Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E383-E384

2016

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)

Annals of oncology, 2014-03, Vol.25 (3), p.689-694

2014

Link zum Volltext

Verfügbarkeit prüfen

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions

Nature communications, 2017-10, Vol.8 (1), p.1197-13, Article 1197

2017

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin (CDDP) and Radiation (RT) versus Cetuximab (C) and RT in the Context of Human Papillomavirus (HPV) and P16 in the Treatment of Locally Advanced Head and Neck Cancer (LAHNC)

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S63-S63

2010

Link zum Volltext

Verfügbarkeit prüfen

861P Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients

Annals of oncology, 2023-10, Vol.34, p.S559-S559

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of Human Papillomavirus and Epstein-Bar Virus in Nasopharyngeal Carcinoma

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1158-1158

2020

Link zum Volltext

Verfügbarkeit prüfen

PO-1550: Radiomics characteristics correlate with immune activation and HPV status in head and neck cancer

Radiotherapy and oncology, 2020-11, Vol.152, p.S838-S839

2020

Link zum Volltext

Verfügbarkeit prüfen

Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1133-1133

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of p16-Positive EBV-Negative Nasopharyngeal Carcinoma Treated with Definitive Chemoradiation at a Large North American Cancer Center

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.E365-E365

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV Positive Oropharyngeal Cancer (OPC)

International journal of radiation oncology, biology, physics, 2020-04, Vol.106 (5), p.1138-1138

2020

Link zum Volltext

Verfügbarkeit prüfen

Identifying Biological Subtypes of Head and Neck Squamous Cell Carcinoma (HNSCC) From Contrast Enhanced CT Scans Using Radiomic and the Cancer Genome Atlas (TCGA)

International journal of radiation oncology, biology, physics, 2018-11, Vol.102 (3), p.S60-S61

2018

Link zum Volltext

Verfügbarkeit prüfen

Radio‐frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and ‘TUNEL’ study

Liver international, 2006-08, Vol.26 (6), p.746-751

2006

Link zum Volltext

Verfügbarkeit prüfen

A Personalized Approach Using Hypoxia Resolution to Guide Curative-Intent Radiation Therapy Dose-Reduction to 30 Gy: A Novel De-escalation Paradigm for HPV-Associated Oropharynx Cancers Treated With Concurrent Chemoradiation Therapy

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S136-S136

2017

Link zum Volltext

Verfügbarkeit prüfen

Parallel Phase I Studies of Two Schedules of Bkm120 Plus Carboplatin and Paclitaxel for Patients with Advanced Solid Tumors

Annals of oncology, 2014-09, Vol.25, p.iv156

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(27)
Humans
(25)
Aged
(17)
Female
(17)
Male
(16)
Middle Aged
(16)
Pathology
(12)
Adult
(11)
Aged, 80 And Over
(10)
Oncology
(9)
Tumors
(9)
Mutation
(7)
Cancer
(6)
Hematology, Oncology And Palliative Medicine
(6)
Pathology And Forensic Medicine
(6)
Radiology
(6)
Neoplasm Invasiveness
(5)
Original
(5)
Surgery
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)

Malignant Progression in IPMN: A Cohort Analysis of Patients Initially Selected for Resection or Observation

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach

Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

Can Metabolic Tumor Volume Further Risk Stratify Patients Eligible for Treatment Deintensification in the Newly Proposed HPV-Associated Oropharyngeal Cancer Staging System?

Comparison of Outcomes Following Recurrence or Metastasis in HPV+ and HPV- Oropharyngeal Carcinoma Treated With Definitive Chemoradiation Using IMRT

Patterns of Regional Nodal Failure Following Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma

Natural History Following Recurrence After Definitive Locoregional Treatment in 1000+ Cases of Locally Advanced Head and Neck Squamous Cell Carcinoma

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions

Cisplatin (CDDP) and Radiation (RT) versus Cetuximab (C) and RT in the Context of Human Papillomavirus (HPV) and P16 in the Treatment of Locally Advanced Head and Neck Cancer (LAHNC)

861P Combined patient specific tumor and HPV sequencing enables high sensitivity detection of ctDNA in HPV-associated oropharyngeal carcinoma patients

Prognostic significance of Human Papillomavirus and Epstein-Bar Virus in Nasopharyngeal Carcinoma

PO-1550: Radiomics characteristics correlate with immune activation and HPV status in head and neck cancer

Profiling the Spatial Composition of the Hypoxic Tumor-Immune Microenvironment through Multiplex Immunohistochemistry in a Prospective cohort of HPV Associated Oropharynx Cancer

Outcomes of p16-Positive EBV-Negative Nasopharyngeal Carcinoma Treated with Definitive Chemoradiation at a Large North American Cancer Center

Genetic and micro-environmental factors influencing response to definitive 30Gy chemo-radiotherapy (chemoRT) in HPV Positive Oropharyngeal Cancer (OPC)

Identifying Biological Subtypes of Head and Neck Squamous Cell Carcinoma (HNSCC) From Contrast Enhanced CT Scans Using Radiomic and the Cancer Genome Atlas (TCGA)

Radio‐frequency ablation of hepatocellular carcinoma before liver transplantation: a histologic and ‘TUNEL’ study

A Personalized Approach Using Hypoxia Resolution to Guide Curative-Intent Radiation Therapy Dose-Reduction to 30 Gy: A Novel De-escalation Paradigm for HPV-Associated Oropharynx Cancers Treated With Concurrent Chemoradiation Therapy

Parallel Phase I Studies of Two Schedules of Bkm120 Plus Carboplatin and Paclitaxel for Patients with Advanced Solid Tumors

Suchergebnisse filtern